Have a feature idea you'd love to see implemented?
Let us know!
SIBN SI-BONE Inc
Price (delayed)
$13.85
Market cap
$577.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.01
Enterprise value
$590.31M
SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a
Highlights
The EPS rose by 25% YoY and by 7% QoQ
The company's revenue rose by 21% YoY and by 4.6% QoQ
SI-BONE's quick ratio has decreased by 23% YoY and by 7% QoQ
The equity fell by 7% YoY
Key stats
What are the main financial stats of SIBN
Market
Valuations
Earnings
Shares outstanding
41.69M
Market cap
$577.46M
Enterprise value
$590.31M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.46
Price to sales (P/S)
3.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.92
Revenue
$150.71M
EBIT
-$37.31M
EBITDA
-$32.13M
Free cash flow
-$25.98M
Per share
Balance sheet
Liquidity
EPS
-$1.01
Free cash flow per share
-$0.63
Book value per share
$4
Revenue per share
$3.65
TBVPS
$5.42
Total assets
$223.84M
Total liabilities
$59.11M
Debt
$38.42M
Equity
$164.73M
Working capital
$180.27M
Debt to equity
0.23
Current ratio
9.17
Quick ratio
7.99
Net debt/EBITDA
-0.4
Margins
Efficiency
Dividend
EBITDA margin
-21.3%
Gross margin
77.7%
Net margin
-27.1%
Operating margin
-30.4%
Return on assets
-18%
Return on equity
-24.3%
Return on invested capital
-17.9%
Return on capital employed
-18.5%
Return on sales
-24.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SIBN stock price
How has the SI-BONE stock price performed over time
Intraday
1.84%
1 week
0.29%
1 month
-13.11%
1 year
-33.35%
YTD
-34.02%
QTD
-0.93%
Financial performance
How have SI-BONE's revenue and profit performed over time
Revenue
$150.71M
Gross profit
$117.09M
Operating income
-$45.8M
Net income
-$40.85M
Gross margin
77.7%
Net margin
-27.1%
SI-BONE's net margin has increased by 29% YoY and by 9% from the previous quarter
The company's revenue rose by 21% YoY and by 4.6% QoQ
The company's operating margin rose by 21% YoY and by 8% QoQ
SI-BONE's net income has increased by 14% YoY and by 5% QoQ
Growth
What is SI-BONE's growth rate over time
Valuation
What is SI-BONE stock price valuation
P/E
N/A
P/B
3.46
P/S
3.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.92
The EPS rose by 25% YoY and by 7% QoQ
SIBN's P/B is 36% below its 5-year quarterly average of 5.4 and 20% below its last 4 quarters average of 4.3
The equity fell by 7% YoY
The P/S is 49% less than the 5-year quarterly average of 7.4 and 25% less than the last 4 quarters average of 5.1
The company's revenue rose by 21% YoY and by 4.6% QoQ
Efficiency
How efficient is SI-BONE business performance
The ROE has grown by 40% YoY and by 3.2% from the previous quarter
The ROIC has grown by 39% YoY and by 14% from the previous quarter
SI-BONE's ROA has increased by 34% YoY and by 4.3% from the previous quarter
The ROS rose by 30% YoY and by 10% QoQ
Dividends
What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SIBN.
Financial health
How did SI-BONE financials performed over time
SI-BONE's quick ratio has decreased by 23% YoY and by 7% QoQ
The current ratio has declined by 21% year-on-year and by 6% since the previous quarter
SI-BONE's debt is 77% less than its equity
The equity fell by 7% YoY
The debt to equity is up by 4.5% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.